Pronociceptive role of dynorphins in uninjured animals: N -ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 113 (3) , 301-309
Abstract
Intrathecal (i.t.) administration into mice of N-ethylmaleimide (NEM), a cysteine protease inhibitor, produced a characteristic behavioral response, the biting and/or licking of the hindpaw and the tail along with slight hindlimb scratching directed toward the flank. The behavior induced by NEM was inhibited by the intraperitoneal injection of morphine. We have recently reported that dynorphin A and, more potently big dynorphin, consisting of dynorphins A and B, produce the same type of nociceptive response whereas dynorphin B does not [Tan-No K, Esashi A, Nakagawasai O, Niijima F, Tadano T, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism. Brain Res 2002;952:7-14]. The NEM-induced nociceptive behavior was inhibited by pretreatment with dynorphin A- or dynorphin B-antiserum and each antiserum also reduced the nociceptive effects of i.t.-injected synthetic big dynorphin. The characteristic NEM-evoked response was not observed in prodynorphin knockout mice. Naloxone, an opioid receptor antagonist, had no effects on the NEM-induced behavior. Ifenprodil, arcaine and agmatine, antagonists at the polyamine recognition site on the N-methyl-D-aspartate (NMDA) receptor ion-channel complex, and MK-801, an NMDA ion-channel blocker inhibited the NEM-induced effects. Ro25-6981, an antagonist of the NMDA receptor subtype containing NR2B subunit was not active. NEM completely inhibited degradation of dynorphin A by soluble and particulate fractions of mouse spinal cord. Collectively, the results demonstrate that endogenous prodynorphin-derived peptides are pronociceptive in uninjured animals, and required for the NEM-induced behavior. The NEM effects may be mediated through inhibition of the degradation of endogenous dynorphins, presumably big dynorphin that in turn activates the NMDA receptor ion-channel complex by acting on the polyamine recognition site.Keywords
This publication has 41 references indexed in Scilit:
- No DREAM, No PainCell, 2002
- NMDA receptor antagonists as analgesics: focus on the NR2B subtypeTrends in Pharmacological Sciences, 2001
- Dynorphin: friend or foe?Pain, 2000
- Dynorphin A (1–13) Neurotoxicity in Vitro: Opioid and Non-Opioid Mechanisms in Mouse Spinal Cord NeuronsExperimental Neurology, 1999
- Activity-dependent neuronal plasticity following tissue injury and inflammationTrends in Neurosciences, 1992
- Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammationBrain Research, 1991
- Formation of [Leu5]Enkephalin from Dynorphin A(1–8) by Rat Central Nervous Tissue In VitroJournal of Neurochemistry, 1990
- The Posttranslational Processing of Prodynorphin in the Rat Anterior Pituitary*Endocrinology, 1989
- Species-Specific Processing of Prodynorphin in the Posterior Pituitary of Mammals*Endocrinology, 1987
- A general procedure for analysis of proenkephalin B derived opioid peptidesRegulatory Peptides, 1985